Received Jul 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AMB064A | — |
Only diluent administered; Only diluent administered; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 18-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMB064A, expiry date 31-DEC-2025) for prophylaxis. On 03-JUL-2025, the patient received Menveo. On 03-JUL-2025, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: Only diluent administered) and inappropriate dose of vaccine administered (Verbatim: Only diluent administered). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 03-JUL-2025 On 3rd July 2025, a pharmacist called to report that an 18-year-old patient had received only the diluent component of Menveo earlier that day (date of reporting), which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered. The pharmacist stated, he/she had not mixed it beforehand. They also mentioned that the dose would be readministered later that same day just to be safe.